The Drug Delivery Systems Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Drug Delivery Systems Global Market Report 2025 has shown significant growth in the recent years. The market size, which was $41.17 billion in 2024, is expected to increase to $44.21 billion in 2025. This represents a compound annual growth rate (CAGR) of 7.4%.
The Drug Delivery Systems Global Market Report 2025 projects that the drug delivery systems market will grow to $58.64 billion by 2029, with a compound annual growth rate (CAGR) of 7.3%.
Download Your Free Sample of the 2025 Drug Delivery Systems Market Report and Uncover Key Trends Now!The drug delivery systems market covered in this report is segmented –
1) By Type: Injection-Based Drug Delivery System, Oral Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transmucosal Drug Delivery System
2) By Material: Polymer-Based Drug Delivery Systems, Lipid-Based Drug Delivery Systems, Inorganic Drug Delivery Systems, Biologics-Based Drug Delivery Systems, Hybrid Drug Delivery Systems
3) By Application: Infectious Disease, Oncology, Ophthalmology, Urology, Diabetes, Central Nervous System, Other Applications
4) By End-User: Hospitals, Pharmaceutical Companies, Research Institutions, Homecare Settings, Diagnostic Laboratories
The key drivers in the drug delivery systems marketare:
• Growing focus on personalized medicine
• Expanding pipeline of complex and sensitive drugs
• Rising prevalence of rare and orphan diseases
• Favorable regulatory pathways for innovative delivery systems
The key trends in the drug delivery systems market are:
• Development of nanotechnology-based drug delivery systems is a major upcoming trend.
• Innovations in controlled-release and sustained-release technologies are shaping the future of the market.
• Advances in biologics and biosimilars requiring specialized delivery reflects another key trend.
• There is a substantial trend towards the development of targeted delivery systems for oncology and integration of smart drug delivery devices.
Major companies in the drug delivery systems market are:
• Pfizer Inc.
• Johnson & Johnson
• F. Hoffmann-La Roche AG
• Merck & Co. Inc.
• AbbVie Inc.
• Bayer AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Abbott Laboratories Inc.
• Novartis AG
• GlaxoSmithKline PLC
• Eli Lilly and Company
• Amgen Inc.
• Becton, Dickinson and Company
• Teva Pharmaceutical Industries Ltd.
• Boston Scientific Corporation
• Tandem Diabetes
• Pacira Biosciences
• Poseida Therapeutics
• Universal Stabilization Technologies Inc.
• Spectrum Pharmaceuticals Inc.
• VasoRx Inc.
North America was the largest region in the drug delivery system market in 2024